<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Restorative therapies in Parkinson's disease</title>
  </titleInfo>
  <name type="personal">
    <namePart>Brundin, Patrik.</namePart>
  </name>
  <name type="personal">
    <namePart>Olanow, C. W. (Charles Warren)</namePart>
    <namePart type="date">1941-</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nyu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">New York, NY</placeTerm>
    </place>
    <publisher>Springer</publisher>
    <dateIssued>2006</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>365 p. : ill. ; 25 cm.</extent>
  </physicalDescription>
  <tableOfContents>Restorative Therapies in a Historical Perspective.- Ethical Issues in the Approaches of Restorative Therapies for Parkinson's Disease.- Evolution of Parkinson's Disease and Treatment Requirements.- What New Treatments are Needed and the Role of Striatal Grafting.- Clinical Trial Design Issues.- Lessons Learnt from Early Clinical Neural Grafting in Parkinson's Disease.- Fetal Nigral Transplantation as a Therapy for Parkinson's Disease.- Imaging of the Parkinsonian Brain in Relation to Restorative Therapy.- Important Aspects of Surgical Methodology for Transplantation in Parkinson's Disease.- Histopathological and Clinical Criteria for Analyzing Transplanted Human Dopamine Cells in Parkinson's Disease.- Dyskinesias and Neural Grafting in Parkinson's Disease.- Porcine Neural Xenotransplantation: Current Status.- Adult-Derived Stem Cells for Transplantation in Parkinson's Disease.- Embryonic Stem Cells for Grafting in Parkinson's Disease.- Delivery of GDNF For Parkinson's Disease: Transition of a Neuroprotective Treatment Strategy from Basic Sciences to Clinical Application.- Genetically Modified Cells as a Source for Grafting in Parkinson'se Disease.- In Vivo Gene Therapy as a Potential Treatment for Parkinson's Disease.</tableOfContents>
  <note type="statement of responsibility">Patrik Brundin, C. Warren Olanow, editors.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Parkinson's disease</topic>
    <topic>Treatment</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Parkinson's disease</topic>
    <topic>Chemotherapy</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Antiparkinsonian agents</topic>
  </subject>
  <classification authority="lcc">RC382 .R47 2006</classification>
  <classification authority="ddc" edition="23">616.833 06 BRU O</classification>
  <identifier type="isbn">9780387299846</identifier>
  <identifier type="isbn">038729984X</identifier>
  <identifier type="lccn">2005935444</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/toc/fy0705/2005935444.html</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/enhancements/fy0823/2005935444-d.html</identifier>
  <location>
    <url displayLabel="Table of contents only">http://www.loc.gov/catdir/toc/fy0705/2005935444.html</url>
  </location>
  <location>
    <url displayLabel="Publisher description">http://www.loc.gov/catdir/enhancements/fy0823/2005935444-d.html</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">DLC</recordContentSource>
    <recordCreationDate encoding="marc">051011</recordCreationDate>
    <recordChangeDate encoding="iso8601">20200303145157.0</recordChangeDate>
    <recordIdentifier source="OSt">14137213</recordIdentifier>
  </recordInfo>
</mods>
